News About Life

Life Biosciences Longevity Company, Prana, Receives Orphan Designation For PBT434 For Treatment of MSA

Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) has today announced the US Food and Drug Administration (FDA) has granted Orphan Drug designation for its lead molecule, PBT434, for the treatment of Multiple System Atrophy (MSA). This is the first time the FDA has granted orphan designation to a drug for the treatment of MSA. Orphan Drug … Continued

Read Full Article

Life Biosciences Announces Closing Of $50 Million Series B Financing Round

BOSTON, Jan. 15, 2019 /PRNewswire/ — Life Biosciences has announced the closing of a Series B financing round of $50 million, according to Tristan Edwards, chief executive officer and co-founder. The Company initially targeted a $25 million round but upsized to meet investor demand. The proceeds of the investment will be used to continue Life Biosciences’ and its Daughter Companies’ … Continued

Read Full Article

Senolytic Therapeutics Kicks Off Q1 with High-Profile Speaking Events Featuring Co-Founders Marc Ramis and Manuel Serrano

FOR IMMEDIATE RELEASE SENOLYTIC THERAPEUTICS KICKS OFF Q1 2019 WITH HIGH-PROFILE SPEAKING EVENTS FEATURING CO-FOUNDERS MARC RAMIS AND MANUEL SERRANO  Barcelona-Based Biotech is a Daughter Company of Life Biosciences  Funded and Supported by Pioneer in the Study of Age-Related Decline   BOSTON, JANUARY 9 — Senolytic Therapeutics, an innovator in senescent cell research and one … Continued

Read Full Article

Life Biosciences LLC Leads Strategic Investment of up to $31.4 Million in Prana

MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 28 December 2018: Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) (“Prana” or “the Company”) has today announced that it has entered into a securities purchase agreement for a lead investment by Boston based Life Biosciences LLC (“Life Biosciences”) to raise up to approximately A$44.5 million (approx. US$31.4 million).  … Continued

Read Full Article

Life Lua, Subsidiary of Life Biosciences, Named Fierce Biotech Innovation Award Winner

FOR IMMEDIATE RELEASE LIFE LUA SUBSIDIARY OF LIFE BIOSCIENCES NAMED FIERCE BIOTECH INNOVATION AWARD WINNER   BOSTON, DECEMBER 13 –Rebecca Willumson, publisher of Fierce Biotech, announced today that Life Lua Technologies Inc., a subsidiary of Life Biosciences Inc., has been named the recipient of the Fierce Innovation Award, Life Sciences Edition, in the Digital Health … Continued

Read Full Article